Chief Scientific Officer (CSO)
LOXIM Industries is seeking a Chief Scientific Officer to lead their pharmaceutical innovation ecosystem and CDMO business. The role is responsible for R&D platform development, analytical laboratory oversight, and driving global portfolio strategy. Candidates must have extensive experience in API development and process chemistry, with a PhD and 20+ years of leadership experience. This executive role focuses on scaling scientific capabilities and building a world-class innovation culture.
50k new jobs listed every day. Install TAL to find more jobs like this.
Experience
20+ years
Function
Research
Work mode
Onsite, India
Company
Tier 2
What you will work on
LOXIM Industries is seeking a Chief Scientific Officer to lead their pharmaceutical innovation ecosystem and CDMO business. The role is responsible for R&D platform development, analytical laboratory oversight, and driving global portfolio strategy. Candidates must have extensive experience in API development and process chemistry, with a PhD and 20+ years of leadership experience. This executive role focuses on scaling scientific capabilities and building a world-class innovation culture.
TAL's take
High-impact C-level role at an established, globally-present industrial firm with clear strategic objectives and significant leadership scope.
Very well-defined executive JD outlining clear scientific, operational, and commercial leadership requirements for a specific pharmaceutical business unit.
Must haves
- 20+ years in pharmaceutical innovation, R&D, or scientific leadership
- PhD in Organic Chemistry, Pharmaceutical Chemistry, or related disciplines
- Proven experience building scientific organizations and innovation platforms
- Strong exposure to APIs, intermediates, CDMO, and CMO environments
- Experience spanning development through commercialization
Tools and skills
Nice to have: biocatalysis, enzymatic chemistry, peptide chemistry.
About the company
Established manufacturing organization since 1977, operating internationally in a specialized B2B sector, but lacks the recognized tech/biotech unicorn engineering brand status.